Eli Lilly and Company et al v. Aurobindo Pharma Limited et al > Summary
Court Case Number 1:22-cv-01114
Filing Date Aug 24, 2022
Court Delaware District Court
Status Unknown
JudgesColm F. Connolly
Plaintiff Attorneys
10INCYTE HOLDINGS CORPORATION
Attorney Name: Jeremy A. Tigan
Morris Nichols Arsht & Tunnell
Incyte
Attorney Name: Marta A. Godecki
Quinn Emanuel Urquhart & Sullivan
Incyte
Attorney Name: Andrew S. Chalson
Quinn Emanuel Urquhart & Sullivan
Incyte
Attorney Name: Michelle L. Ernst
Latham & Watkins
Incyte
Attorney Name: Audra Sawyer
Latham & Watkins
Incyte
Attorney Name: Brenda L. Danek
Latham & Watkins
Incyte
Attorney Name: Adam L. Perlman
Latham & Watkins
Incyte
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Incyte
Attorney Name: Jessica K. Lam
Latham & Watkins
Defendant Attorneys
10Aurobindo Pharma USA
Attorney Name: R. Touhey Myer
Kratz & Barry
Aurobindo Pharma USA
Attorney Name: Michael P. Hogan
Kratz & Barry
Aurobindo Pharma USA
Attorney Name: Timothy H. Kratz
Kratz & Barry
MSN Pharmaceuticals Inc.
Attorney Name: Kaan Ekiner
Cozen O'Connor
Aurobindo Pharma USA
Attorney Name: Aaron S. Lukas
Duane Morris LLP
Aurobindo Pharma USA
Attorney Name: William Blake Coblentz
Duane Morris LLP
MSN Pharmaceuticals Inc.
Attorney Name: David E. Wang
Winston & Strawn
MSN Pharmaceuticals Inc.
Attorney Name: Aaron S. Lukas
Cozen O'Connor
MSN Pharmaceuticals Inc.
Attorney Name: Keri L. Schaubert
Cozen O'Connor
MSN Pharmaceuticals Inc.
Attorney Name: William Blake Coblentz
Cozen O'Connor
Related Patents
Doc No | Title | Issue date |
---|---|---|
08420629 | Azetidine and cyclobutane derivatives as JAK inhibitors | Apr 16, 2013 |
08158616 | Azetidine and cyclobutane derivatives as JAK inhibitors | Apr 17, 2012 |